Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Tenax Therapeutics, Inc. (TENX) had Return on Equity of -10.50% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-10.85M |
|
-- |
|
-- |
|
$11.79M |
|
$-11.79M |
|
$0.94M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-10.85M |
|
$-11.79M |
|
$-11.79M |
|
39.57M |
|
39.57M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$105.86M |
|
-- |
|
-- |
|
$105.86M |
|
$2.53M |
|
-- |
|
-- |
|
$2.53M |
|
$103.33M |
|
$103.33M |
|
$103.33M |
|
4.15M |
|
| Cash Flow Statement Financials | |
$-13.23M |
|
-- |
|
$23.84M |
|
$94.85M |
|
$105.46M |
|
$10.61M |
|
$8.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
41.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-10.50% |
-10.50% |
|
-10.25% |
|
-10.50% |
|
$24.91 |
|
$-0.33 |
|
$-0.33 |
|